Scholars@Duke

The Past, Present, and Future of Treatment Intensification for Metastatic Hormone-Sensitive Prostate Cancer.

Publication ,  Journal Article
McManus, HD; Armstrong, AJ
Published in: J Clin Oncol
July 10, 2023
Published version (DOI) Link to item

Duke Scholars

Hannah Dzimitrowicz McManus
Author Hannah Dzimitrowicz McManus Medicine, Medical Oncology
Andrew John Armstrong
Author Andrew John Armstrong Medicine, Medical Oncology

Published In

J Clin Oncol

DOI

10.1200/JCO.23.00323

EISSN

1527-7755

Publication Date

July 10, 2023

Volume

41

Issue

20

Start / End Page

3576 / 3579

Location

United States

Related Subject Headings

  • Prostatic Neoplasms
  • Oncology & Carcinogenesis
  • Male
  • Humans
  • Hormones
  • Docetaxel
  • Androgen Antagonists
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
McManus, H. D., & Armstrong, A. J. (2023). The Past, Present, and Future of Treatment Intensification for Metastatic Hormone-Sensitive Prostate Cancer. J Clin Oncol, 41(20), 3576–3579. https://doi.org/10.1200/JCO.23.00323
McManus, Hannah D., and Andrew J. Armstrong. “The Past, Present, and Future of Treatment Intensification for Metastatic Hormone-Sensitive Prostate Cancer.” J Clin Oncol 41, no. 20 (July 10, 2023): 3576–79. https://doi.org/10.1200/JCO.23.00323.
McManus, Hannah D., and Andrew J. Armstrong. “The Past, Present, and Future of Treatment Intensification for Metastatic Hormone-Sensitive Prostate Cancer.” J Clin Oncol, vol. 41, no. 20, July 2023, pp. 3576–79. Pubmed, doi:10.1200/JCO.23.00323.
McManus HD, Armstrong AJ. The Past, Present, and Future of Treatment Intensification for Metastatic Hormone-Sensitive Prostate Cancer. J Clin Oncol. 2023 Jul 10;41(20):3576–3579.

Published In

J Clin Oncol

DOI

10.1200/JCO.23.00323

EISSN

1527-7755

Publication Date

July 10, 2023

Volume

41

Issue

20

Start / End Page

3576 / 3579

Location

United States

Related Subject Headings

  • Prostatic Neoplasms
  • Oncology & Carcinogenesis
  • Male
  • Humans
  • Hormones
  • Docetaxel
  • Androgen Antagonists
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences